DrugId:  1
1. Name:  Tesidolumab
2. Groups:  Investigational
3. Description:  Tesidolumab has been used in trials studying the treatment of Geographic Atrophy, Non-infectious Panuveitis, Exudative Macular Degeneration, Non-infectious Posterior Uveitis, and Age-related Macular Degeneration, among others.
4. Indication:  Not Available
